158 related articles for article (PubMed ID: 37817888)
1. Real-world experience with histological confirmation of clinical response of squamous cell carcinoma to topical tirbanibulin.
Moore A; Hurley K; Moore SA; Moore L
JAAD Case Rep; 2023 Oct; 40():141-144. PubMed ID: 37817888
[No Abstract] [Full Text] [Related]
2. Rapid resolution of recalcitrant basal cell carcinoma of the ear with topical tirbanibulin.
Moore A; Hurley K; Moore SA
JAAD Case Rep; 2022 Oct; 28():11-13. PubMed ID: 36090193
[No Abstract] [Full Text] [Related]
3. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
Blauvelt A; Kempers S; Lain E; Schlesinger T; Tyring S; Forman S; Ablon G; Martin G; Wang H; Cutler DL; Fang J; Kwan MR;
N Engl J Med; 2021 Feb; 384(6):512-520. PubMed ID: 33567191
[TBL] [Abstract][Full Text] [Related]
4. 1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses.
Dao DD; Sahni VN; Sahni DR; Balogh EA; Grada A; Feldman SR
Ann Pharmacother; 2022 Apr; 56(4):494-500. PubMed ID: 34301153
[TBL] [Abstract][Full Text] [Related]
5. Topical tirbanibulin eradication of periungual squamous cell carcinoma.
Moore AY; Moore S
JAAD Case Rep; 2021 Aug; 14():101-103. PubMed ID: 34307817
[No Abstract] [Full Text] [Related]
6. Topical tirbanibulin resolves recalcitrant condyloma acuminata: Retrospective case series.
Moore AY; Hurley K; Moore S; Moore L
JAAD Case Rep; 2023 Jul; 37():58-60. PubMed ID: 37492432
[No Abstract] [Full Text] [Related]
7. Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action.
Schlesinger T; Stockfleth E; Grada A; Berman B
Clin Cosmet Investig Dermatol; 2022; 15():2495-2506. PubMed ID: 36415541
[TBL] [Abstract][Full Text] [Related]
8. Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Heppt MV; Dykukha I; Graziadio S; Salido-Vallejo R; Chapman-Rounds M; Edwards M
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329979
[TBL] [Abstract][Full Text] [Related]
9. Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study.
Kirchberger MC; Gfesser M; Erdmann M; Schliep S; Berking C; Heppt MV
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510952
[TBL] [Abstract][Full Text] [Related]
10. Profile of Tirbanibulin for the Treatment of Actinic Keratosis.
Berman B; Grada A; Berman DK
J Clin Aesthet Dermatol; 2022 Oct; 15(10 Suppl 1):S3-S10. PubMed ID: 36408375
[TBL] [Abstract][Full Text] [Related]
11. Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis.
Gilaberte Y; Fernández-Figueras MT
Actas Dermosifiliogr; 2022 Jan; 113(1):58-66. PubMed ID: 35249711
[TBL] [Abstract][Full Text] [Related]
12. Tirbanibulin: Topical Treatment for Actinic Keratosis.
Dlott AH; Di Pasqua AJ; Spencer SA
Clin Drug Investig; 2021 Sep; 41(9):751-755. PubMed ID: 34351607
[TBL] [Abstract][Full Text] [Related]
13. Focused update: Guidelines of care for the management of actinic keratosis.
Eisen DB; Dellavalle RP; Frazer-Green L; Schlesinger TE; Shive M; Wu PA
J Am Acad Dermatol; 2022 Aug; 87(2):373-374.e5. PubMed ID: 35439607
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus 57 positivity in periungual squamous cell carcinoma eradicated by topical tirbanibulin.
Moore AY; Moore SA; He Q; Rady P; Tyring SK
JAAD Case Rep; 2022 Apr; 22():58-59. PubMed ID: 35340732
[No Abstract] [Full Text] [Related]
15. Tirbanibulin for the Treatment of Actinic Keratosis: A Review.
Miller AC; Adjei S; Temiz LA; Tyring SK
Skin Therapy Lett; 2022 Jul; 27(4):4-7. PubMed ID: 35857917
[TBL] [Abstract][Full Text] [Related]
16. Treating locally advanced and metastatic cutaneous squamous cell carcinoma with anti-PD-1 drugs: Real-world experience in 72 patients.
Picavia RM; DeSimone J; Jang S; Stahl C
JAAD Int; 2024 Mar; 14():50-51. PubMed ID: 38076396
[No Abstract] [Full Text] [Related]
17. Topical Treatments for Basal Cell Carcinoma and Actinic Keratosis in the United States.
Tan IJ; Pathak GN; Silver FH
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568743
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.
Lee EH; Klassen AF; Nehal KS; Cano SJ; Waters J; Pusic AL
J Am Acad Dermatol; 2013 Aug; 69(2):e59-67. PubMed ID: 23102770
[TBL] [Abstract][Full Text] [Related]
19. The Danish Nonmelanoma Skin Cancer Dermatology Database.
Lamberg AL; Sølvsten H; Lei U; Vinding GR; Stender IM; Jemec GB; Vestergaard T; Thormann H; Hædersdal M; Dam TN; Olesen AB
Clin Epidemiol; 2016; 8():633-636. PubMed ID: 27822110
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
